EP Patent

EP0032309A3 — Production of catalyst component, catalyst and use thereof

Assigned to Imperial Chemical Industries Ltd · Expires 1981-08-05 · 45y expired

What this patent protects

A catalyst component is a transition metal composition which is obtained by reacting together an inert particulate material, an organic magnesium compound, a halogen-­ containing compound such as carbon tetrachloride silicon tetrachloride or boron trichloride and a specified t…

USPTO Abstract

A catalyst component is a transition metal composition which is obtained by reacting together an inert particulate material, an organic magnesium compound, a halogen-­ containing compound such as carbon tetrachloride silicon tetrachloride or boron trichloride and a specified transition metal compound such as VOCl₃, bis(n-butoxy) titanium dich­ loride or zirconium tetrabenzyl. The catalyst component obtained can be used, together with an organic metal com­ pound, to give an olefin polymerisation catalyst. The catalyst can be used to effect the polymerisation of olefin monomers, for example, the copolymerisation of ethylene with an alpha-olefin monomer such as butene-1 in a fluidised bed reactor.

Drugs covered by this patent

Patent Metadata

Patent number
EP0032309A3
Jurisdiction
EP
Classification
Expires
1981-08-05
Drug substance claim
No
Drug product claim
No
Assignee
Imperial Chemical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.